A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Taofeek Kunle Owonikoko, Kristin Ann Higgins, Zhengjia Chen, Chao Zhang, Rathi Narayana Pillai, Conor Ernst Steuer, Nabil F. Saba, Suchita Pakkala, Dong Moon Shin, Guojing Zhang, Shuhua Wang, Mohammed S Hossain, Tyler Beardslee, Anne Engelhart, Janine Revenig, Fadlo Khuri, Walter John Curran, Sagar Lonial, Edmund K. Waller, Suresh S. Ramalingam
Institutions: Emory University, Winship Cancer Institute, Emory Clinic
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947847394